Showing results (141-150 of 182) with videos related to

Sort By:
Pageof 19
Molecular Psychiatry|May 29, 2026
Assessing the de novo paradigm in sporadic early-onset Alzheimer disease triosAline Zarea, Kevin Cassinari, François Lecoquierre, et al.
Nature Neuroscience|June 20, 2017
A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's diseaseKuan-Lin Huang, Edoardo Marcora, Anna A Pimenova, et al.
Translational Psychiatry|February 2, 2019
Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer's diseaseMaria Carolina Dalmasso, Luis Ignacio Brusco, Natividad Olivar, et al.
The American Journal of Clinical Nutrition|January 22, 2016
Interaction of methylation-related genetic variants with circulating fatty acids on plasma lipids: a meta-analysis of 7 studies and methylation analysis of 3 studies in the Cohorts for Heart and Aging Research in Genomic Epidemiology consortiumYiyi Ma, Jack L Follis, Caren E Smith, et al.
Acta Neuropathologica|March 14, 2020
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairmentLuca Kleineidam, Vincent Chouraki, Tomasz Próchnicki, et al.
The Lancet. Neurology|September 19, 2020
Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association studyEmma Jones, Holger Hummerich, Emmanuelle Viré, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Non-microglial downregulation of <i>PLCG2</i> impairs synaptic function and elicits Alzheimer disease-related hallmarksAudrey Coulon, Florian Rabiller, Mari Takalo, et al.
Annals of Neurology|June 18, 2011
Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortiumMyriam Fornage, Stephanie Debette, Joshua C Bis, et al.
Nature Reviews. Immunology|December 9, 2024
Neuroinflammation in Alzheimer diseaseMichael T Heneka, Wiesje M van der Flier, Frank Jessen, et al.
Journal of Alzheimer'S Disease : JAD|September 18, 2010
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis studyJean-Charles Lambert, Kristel Sleegers, Antonio González-Pérez, et al.
Pageof 19